OP15 Immunosuppressive co-treatment with adalimumab (ADA) may be more effective than ADA monotherapy for maintaining remission in Crohn's disease (CD)

✍ Scribed by C. Reenaers; E. Louis; J. Belaiche; S. Keshav; S. Travis

• Book ID: 119636487
• Publisher: Oxford University Press
• Year: 2012
• Tongue: English
• Weight: 46 KB
• Volume: 6
• Category: Article
• ISSN: 1873-9946
• DOI: 10.1016/s1873-9946(12)60016-6